Inventor
DE VRY JEAN-MARIE-VIKTOR
DE29 patents
Patents
29 patentsUS6573278B2Jun 3, 2003
Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
BAYER AG61 citations95
US6284788B1Sep 4, 2001
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG65 citations95
US6545050B1Apr 8, 2003
Aryl sulphonamide amino acid esters and analogues
BAYER AG30 citations92
US6194428B1Feb 27, 2001
Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
BAYER AG29 citations92
US5696136ADec 9, 1997
Method of treating psychosis using azaheterocyclylmethyl
BAYER AG26 citations92
US5670525ASep 23, 1997
Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
BAYER AG33 citations92
US6462074B1Oct 8, 2002
Substituted α, β-anellated butyrolactones
BAYER AG17 citations83
US6121284ASep 19, 2000
2,3-bridged 1,4-dihydropyridines, and their use as medicaments
BAYER AG10 citations74
US5990121ANov 23, 1999
Use of 1,2-bridged 1,4-dihydropyridines as medicaments
BAYER AG9 citations74
US5942526AAug 24, 1999
5-acyl-1,4-dihydropyridines
BAYER AG9 citations74
US5760073AJun 2, 1998
Substituted 4H-pyrans
BAYER AG8 citations74
US5696137ADec 9, 1997
Azaheterocyclymethyl-chromans
BAYER AG10 citations74
US6525087B2Feb 25, 2003
Use of known agonists of the central cannabinoid receptor CB1
BAYER AG10 citations73
US6147087ANov 14, 2000
Use of 1,2-Bridged 1,4-dihydropyridines as medicaments
BAYER AG4 citations63
US5955482ASep 21, 1999
Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
BAYER AG2 citations63
US5874462AFeb 23, 1999
Use of substituted 6-amino-4H-pyrans
BAYER AG4 citations63
US5861394AJan 19, 1999
Use of N-substituted phenothiazines
BAYER AG5 citations63
US5756515AMay 26, 1998
Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as medicaments
BAYER AG5 citations63
US5665741ASep 9, 1997
1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases
BAYER AG5 citations63
US5646166AJul 8, 1997
Use of 5-acyl-1,4-dihydropyridines
BAYER AG4 citations63
US5719181AFeb 17, 1998
Use of acyl-substituted aminopyrans
BAYER AG2 citations62
US5652264AJul 29, 1997
Cyclohexadiene derivatives useful in the treatment of depression
BAYER AG0 citations52
US5530014AJun 25, 1996
Cyclohexadiene derivatives
BAYER AG1 citations52
US6756409B2Jun 29, 2004
Phenoxyphenyl alkanesulphonates
BAYER AG0 citations51
US6723718B2Apr 20, 2004
Substituted α, β-anellated butyrolactones
BAYER AG1 citations51
US6433004B1Aug 13, 2002
Substituted β,γ-anellated lactones
BAYER AG1 citations51
US6376539B1Apr 23, 2002
Substituted bicyclic lactones
BAYER AG2 citations51
US5652251AJul 29, 1997
6-amino-1,4-dihydropyridine compounds as medicaments for treatment of the central nervous system, and processes for their preparation
BAYER AG0 citations42
US6919470B2Jul 19, 2005
Aryl and heteroaryl sulfonates
BAYER AG0 citations41